$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Corosolic acid formulation and its application for weight-loss management and blood sugar balance 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/64
  • A61K-009/00
  • A61K-036/00
출원번호 UP-0825920 (2001-04-03)
등록번호 US-7713546 (2010-06-03)
발명자 / 주소
  • Udell, Ronald G.
  • Hari, Siva P.
출원인 / 주소
  • Soft Gel Technologies, Inc.
대리인 / 주소
    Dorsey & Whitney LLP
인용정보 피인용 횟수 : 0  인용 특허 : 40

초록

A soft gelatin capsule and method to deliver an efficable dose of Lagerstroemia speciosa L. (marketed by Soft Gel Technologies under the trademark Glucosol™) for the assistance and maintenance of moderate weight loss through blood sugar maintenance. The product relies on the effects of coroso

대표청구항

The invention claimed is: 1. A unitary soft gel capsule for oral administration, prepared by a process comprising the steps of: heating an oil in a container; adding filler to provide a mixture; adding Corosolic acid; stirring the mixture; and encapsulating the mixture in a soft gel capsule. 2.

이 특허에 인용된 특허 (40)

  1. Odaka Hiroyuki,JPX ; Nakaoka Ichiro,JPX ; Suzuki Yoshiharu,JPX, Agent for treating high-risk impaired glucose tolerance.
  2. Iwata Kazuyuki (Eniwa JPX) Watanabe Kazuhiro (Eniwa JPX) Kimura Yoshiyuki (Kyoto JPX) Okuda Hiromichi (Matsuyama JPX), Algin-containing food and beverage.
  3. Schmidt Delf (Wuppertal-Vohwinkel DT) Puls Walter (Wuppertal-Elberfeld DT), Amylase inhibitor from wheat gluten using alcohol.
  4. Klose ; deceased Volker (late of Straubing DEX by Gabriele Klose ; heir), Ball-game racket, particularly a tennis racket.
  5. Udel, Ronald G., Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing.
  6. Cheng Nanzheng,CNX, Composition and method for increasing insulin activity.
  7. Shanmugasundaram Edayatimangalam Raja Bhavani,INX ; Shanmugasundaram Kalathinkal Radha,INX ; Hebert Rolland ; Malik Sohail ; Baker Michael, Compositions for treating and preventing diabetes, impaired glucose tolerance and related symptoms, and methods for prep.
  8. Carniglia Francis J. (Windsor Locks CT) Kenyon Alan J. (Hartford CT), Compositions of matter and methods for increasing intracellular ATP levels and physical performance levels and for incre.
  9. Udell, Ronald G.; Hari, Siva P., Corosolic acid formulation and its application for weight-loss management and blood sugar balance.
  10. Fallon Renee A. (Sunnyvale CA) Wilson Donald R. (San Francisco CA), Device for administering drug transdermally which provides an initial pulse of drug.
  11. Gilles Stephanie M. ; Wolf Bryan W. ; Zinker Bradley A. ; Garleb Keith A. ; Walton Joseph E. ; Nicholson Sue E., Diabetic nutritionals and method of using.
  12. Fine Stuart A., Dietary supplement and method of treatment for diabetic control.
  13. Sibalis Dan (Stony Brook NY), Electrical transdermal drug applicator with counteractor and method of drug delivery.
  14. Schmidl Mary K. (Arden Hills MN) Kvamme Candis (Brooklyn Park MN), Enteral nutritional composition having balanced amino acid profile.
  15. Matsutani Etsuya (Kobe JPX) Marui Shogo (Kobe JPX), Glutaminase inhibitory compounds, compositions, and methods of use.
  16. Gorsek, Wayne F., Insulin sensitivity maintenance and blood sugar level maintenance formulation for the prevention and treatment of diabetes.
  17. Burtle Gary J. (Tifton GA) Newton G. Larry (Tifton GA) Blum Stephen A. (Des Moines IA), L-carnitine supplemented catfish diet.
  18. Futoshi Matsuyama JP, Method for inhibiting increase of blood sugar level or lowering blood sugar level with a lagerstroemia extract.
  19. Shug Austin L. (1201 Shorewood Blvd. Madison WI 53705) Keene Bruce W. (North NC State University College of Veterinary Medicine ; 4700 Hillsbourough St. Raleigh NC 27606), Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats.
  20. Ribnicky, David M.; Raskin, Ilya, Method for treating type 2 diabetes with an extract of Artemisia.
  21. Blum Rene (Rheinfelden CHX) Leibetseder Josef (Vienna ATX), Method of increasing the hatchability of eggs by feeding hens carnitine.
  22. Robert P. LaGrone, Method of treating humans with diseases characterized by high secretion of cytokines from macrophage cells.
  23. Shug Austin L. (5322 Lighthouse Bay Dr. Madison WI 53704), Method of treating reduced insulin-like growth factor and bone loss associated with aging.
  24. Murao, Sawao, Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus.
  25. Wilfong Debra L. (Lake Elmo MN) Rolando Richard J. (Oakdale MN), Multilayered barrier structures.
  26. DeFelice Stephen L. (235 Munsee Way Westfield NJ 07090), Nutritional and/or dietary composition and method of using the same.
  27. Brantman Eugene R. (Richardson TX), Nutritional composition for enhancing skeletal muscle adaptation to exercise training.
  28. Tucker Mark J. (Round Steps ; High Street Stow-on-the-Wold ; Gloucester GL54 1DL GBX) Tucker Mark R. (P.O. Box 23530 Bahrain BHX), Occlusive body for administering a physiologically active substance.
  29. Bremer Klaus-Dieter (Allschwil CHX) Sawlewicz Pavel (Basel CHX), Pharmaceutical composition comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor.
  30. Cavazza Claudio (35 ; Via Marocco 00144 Rome ITX), Pharmaceutical composition comprising an acyl-carnitine, for treating peripheral vascular diseases.
  31. White Richard K. (Maineville OH), Pharmaceutical compositions and process of manufacture thereof.
  32. Sibalis Dan (Stony Brook NY), Pulsating transdermal drug delivery system.
  33. Okutani, Tetsuya; Goto, Giichi, Quinone derivatives.
  34. Farhadieh Bahram (Libertyville IL) Gokhale Rajeev D. (Vernon Hills IL), Single layer transdermal drug administration system.
  35. Farhadieh Bahram (Libertyville IL) Gokhale Rajeev D. (Vernon Hills IL) Berger Hana (Lincolnshire IL) Vallner Joseph (Mountainview CA), Single layer transdermal drug administration system.
  36. Benecke Arnold G. (Hamilton OH) Kinne Daniel J. (Cincinnati OH) Wnuk Andrew J. (Wyoming OH), Storage-stable transdermal patch.
  37. McPeak Patricia ; Cheruvanky Rukmini ; Cherukuri Reddy Sastry V., Supportive therapy for diabetes, hyperglycemia and hypoglycemia.
  38. Sibalis Dan (Stony Brook NY), Transdermal drug delivery system.
  39. Sibalis Dan (Stony Brook NY), Transdermal drug patch with conductive fibers.
  40. Sibalis Dan (Stony Brook NY), Transdermal drug patch with microtubes.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로